15:48 Mar 21
Accent Microcell Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Accent Microcell Ltd.
Industry Pharmaceuticals
15:48 Mar 21
Quality
0/100
Not Eligible
Valuation
26/100
Expensive Valuation
Technical
35/100
Technically Neutral
Strength
6
Weakness
4
Opportunity
0
Threats
0
18.41 %
ROE %
14.72 %
ROA %
14.34
EPS
77.86
BVPS
0.00 %
Net Profit Margin
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
|---|---|---|---|---|---|
| Net Sales | 132.57 | 165.71 | 204.19 | 245.5 | |
| Operating Expenses + | 121.88 | 152.73 | 184.82 | 206.02 | |
| Raw Material | 99.05 | 120.28 | 153.89 | 131.31 | |
| Increase Decrease in Cost | -8.94 | -6.94 | -9.73 | 14.62 | |
| Other Manufacturing Expense | 0 | 0 | 0 | 0 | |
| Employee Cost | 6.93 | 7.62 | 8.66 | 11.03 | |
| Miscellaneous Expenses | 24.84 | 31.77 | 32 | 126.28 | |
| Operating Profit | 10.69 | 12.98 | 19.37 | 39.48 | |
| Other Income | 2.25 | 1.83 | 2.78 | 3.63 | |
| Depreciation | 3.55 | 4.15 | 4.13 | 4.43 | |
| Interest | 3.38 | 3.07 | 2.53 | 1.15 | |
| Profit before tax and exceptio.. | 6 | 7.59 | 15.49 | 37.53 | |
| Exceptional Items | 0 | 0 | 0 | -1 | |
| PBT | 6 | 7.59 | 15.49 | 36.53 | |
| Provision for Taxation | 1.2 | 1.7 | 2.48 | 6.36 | |
| Net Profit | 4.8 | 5.89 | 13.01 | 30.17 | |
| NET Profit after MI | 0 | 0 | 0 | 0 | |
| EPS | 3.72 | 4.57 | 10.06 | 18.67 | |
| Operating Profit Margin (%) | 8.06 | 7.83 | 9.49 | 16.08 | |
| Net Profit Margin (%) | 3.62 | 3.55 | 6.37 | 12.29 |
ShareHolding
Promoter
FII
Public
Mutual Funds
Other Institutions
All Data in Percentage (%)
| Sep 24 | |
|---|---|
| Promoter | 55.10 |
| FII | 0.00 |
| MF | 0.00 |
| Public | 43.20 |
| Others | 0.00 |
| Others | 1.70 |
| Shareholder | Shares | Holding % |
|---|
Download Our App On:
